Back to search

Peptide record

TPDB42561

TC22 Anticancer standard
22 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42561
TC22
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 22-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
MTVVLLLIVLPLLGGVHSSGIL
Physicochemical Analysis
C106H186N24O26S1
ARNDCEQKFWY
L
2244.85
7.85
1
0
14
+0
-2.65
2.091
212.27
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
3
G
1
H
2
I
7
L
0
K
1
M
0
F
1
P
2
S
1
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 3 H: 1 I: 2 L: 7 K: 0 M: 1 F: 0 P: 1 S: 2 T: 1 W: 0 Y: 0 V: 4
Chemical Descriptors
22
C106H186N24O26S1
2244.85
7.85
+0
-2.65
2.091
Free
L
Linear
Free
Anticancer
Tribolium castaneum
Evidence Records 2 records
Evidence 1 Activity

Activity

Fig 4a
Anticancer

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2019

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Fig 4a
Anticancer

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2019